| 1 |
Yu YH, Zhang HJ, Yang F, Xu L, Liu H. Curcumol, a major terpenoid from Curcumae Rhizoma, attenuates human uterine leiomyoma cell development via the p38MAPK/NF-κB pathway. J Ethnopharmacol 2023;310:116311. [PMID: 36894110 DOI: 10.1016/j.jep.2023.116311] [Reference Citation Analysis]
|
| 2 |
Lozinskaya NA, Bezsonova EN, Dubar M, Melekhina DD, Bazanov DR, Bunev AS, Grigor'eva OB, Klochkov VG, Sokolova EV, Babkov DA, Spasov AA, Sosonyuk SE. 3-Arylidene-2-oxindoles as Potent NRH:Quinone Oxidoreductase 2 Inhibitors. Molecules 2023;28. [PMID: 36770840 DOI: 10.3390/molecules28031174] [Reference Citation Analysis]
|
| 3 |
Huang Z, Zhu S, Han Z, Li C, Liang J, Wang Y, Zhang S, Zhang J. Proteome-Wide Analysis Reveals TFEB Targets for Establishment of a Prognostic Signature to Predict Clinical Outcomes of Colorectal Cancer. Cancers (Basel) 2023;15. [PMID: 36765702 DOI: 10.3390/cancers15030744] [Reference Citation Analysis]
|
| 4 |
Tong T, Lei H, Zhang S, Jiang D, Guan Y, Xing C, Chen H, Yang X, Kang Y, Pang J. Effective Sonosensitizer Delivery by Redox Sensitive Nanoparticles for Prostate Cancer Sonodynamic Therapy via Amplifying Oxidative Stress and Peroxidation. Adv Healthc Mater 2022;11:e2201472. [PMID: 36126678 DOI: 10.1002/adhm.202201472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Ma L, Wei HL, Wang KJ, Meng XY, Ni SQ, Zhou C, Li Y, Yu R, Ma Q. Rhein promotes TRAIL-induced apoptosis in bladder cancer cells by up-regulating DR5 expression. Aging (Albany NY) 2022;14. [PMID: 35985770 DOI: 10.18632/aging.204236] [Reference Citation Analysis]
|
| 6 |
Zhao J, Zhao Z, Hou W, Jiang Y, Liu G, Ren X, Liu K, Liu H, Chen K, Huang H. Quantitative Proteomics Explore the Potential Targets and Action Mechanisms of Hydroxychloroquine. Molecules 2022;27:5175. [PMID: 36014414 DOI: 10.3390/molecules27165175] [Reference Citation Analysis]
|
| 7 |
Mao Z, Zhong L, Zhuang X, Liu H, Peng Y. Curcumenol Targeting YWHAG Inhibits the Pentose Phosphate Pathway and Enhances Antitumor Effects of Cisplatin. Evid Based Complement Alternat Med 2022;2022:3988916. [PMID: 35795276 DOI: 10.1155/2022/3988916] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Wang J, Jin J, Chen T, Zhou Q. Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages. Molecules 2022;27:4345. [DOI: 10.3390/molecules27144345] [Reference Citation Analysis]
|
| 9 |
Zhang R, Pan T, Xiang Y, Zhang M, Xie H, Liang Z, Chen B, Xu C, Wang J, Huang X, Zhu Q, Zhao Z, Gao Q, Wen C, Liu W, Ma W, Feng J, Sun X, Duan T, Lai-han Leung E, Xie T, Wu Q, Sui X. Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19/miR-19b-3p/FTH1 axis. Bioactive Materials 2022;13:23-36. [DOI: 10.1016/j.bioactmat.2021.11.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 10 |
Zhang M, Shen W, Jiang Q, Sun Q, Liu Y, Yang Y, Yin D. Engineering a curcumol-loaded porphyrinic metal-organic framework for enhanced cancer photodynamic therapy. Colloids Surf B Biointerfaces 2022;214:112456. [PMID: 35290822 DOI: 10.1016/j.colsurfb.2022.112456] [Reference Citation Analysis]
|
| 11 |
Nong BL, Meng XW, Wei YY, Zhao HJ, Zhang XX. Design, synthesis, and biological evaluation of C-8 modified curcumol derivatives against colorectal cancer cell lines. J Asian Nat Prod Res 2022;:1-14. [PMID: 35499464 DOI: 10.1080/10286020.2022.2067533] [Reference Citation Analysis]
|
| 12 |
Sun Y, Yang Y, Hu Y, Ouyang L, Sun Z, Yin X, Li N, He Q, Wang Y. Inhibition of nuclear deacetylase Sirtuin-1 induces mitochondrial acetylation and calcium overload leading to cell death. Redox Biology 2022. [DOI: 10.1016/j.redox.2022.102334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Yang L, Xiong H, Li X, Li Y, Zhou H, Lin X, Chan TF, Li R, Lai KP, Chen X. Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19. Front Nutr 2022;9:870370. [DOI: 10.3389/fnut.2022.870370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Yan L, Zhang Z, Liu Y, Ren S, Zhu Z, Wei L, Feng J, Duan T, Sun X, Xie T, Sui X. Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology. Front Mol Biosci 2022;9:862932. [DOI: 10.3389/fmolb.2022.862932] [Reference Citation Analysis]
|
| 15 |
Wang F, Li Z, Chen L, Yang T, Liang B, Zhang Z, Shao J, Xu X, Yin G, Wang S, Ding H, Zhang F, Zheng S. Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1α/NF-κB feedback pathway to inhibit liver fibrosis. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.03.014] [Reference Citation Analysis]
|
| 16 |
Wang Y, Zhang J, Zhong LY, Huang SJ, Yu NN, Ouyang L, Niu YL, Chen JX, Lu CH, He QY. Hsa-miR-335 enhances cell migration and invasion in lung adenocarcinoma through targeting Copine-1. MedComm (2020) 2021;2:810-20. [PMID: 34977878 DOI: 10.1002/mco2.93] [Reference Citation Analysis]
|
| 17 |
Wang Y, Zhang J, Li YJ, Yu NN, Liu WT, Liang JZ, Xu WW, Sun ZH, Li B, He QY. MEST promotes lung cancer invasion and metastasis by interacting with VCP to activate NF-κB signaling. J Exp Clin Cancer Res 2021;40:301. [PMID: 34560900 DOI: 10.1186/s13046-021-02107-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 18 |
Gao GB, Sun Y, Fang RD, Wang Y, Wang Y, He QY. Post-translational modifications of CDK5 and their biological roles in cancer. Mol Biomed 2021;2:22. [PMID: 35006426 DOI: 10.1186/s43556-021-00029-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Tian NN, Zheng YB, Li ZP, Zhang FW, Zhang JF. Histone methylatic modification mediates the tumor-suppressive activity of curcumol in hepatocellular carcinoma via an Hotair/EZH2 regulatory axis. J Ethnopharmacol 2021;280:114413. [PMID: 34265379 DOI: 10.1016/j.jep.2021.114413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Liang JZ, Liang XL, Zhong LY, Wu CT, Zhang J, Wang Y. Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma. Front Oncol 2020;10:617890. [PMID: 33732636 DOI: 10.3389/fonc.2020.617890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Sun J, Prabhu N, Tang J, Yang F, Jia L, Guo J, Xiao K, Tam WL, Nordlund P, Dai L. Recent advances in proteome-wide label-free target deconvolution for bioactive small molecules. Med Res Rev 2021. [PMID: 33533067 DOI: 10.1002/med.21788] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 22 |
Zhang J, Sun Y, Zhong LY, Yu NN, Ouyang L, Fang RD, Wang Y, He QY. Structure-based discovery of neoandrographolide as a novel inhibitor of Rab5 to suppress cancer growth. Comput Struct Biotechnol J 2020;18:3936-46. [PMID: 33335690 DOI: 10.1016/j.csbj.2020.11.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
